La Jolla Pharmaceutical Company, a subsidiary of Innoviva, Inc., is dedicated to the commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases. La Jolla markets GIAPREZA® (angiotensin II) injection and XERAVA® (eravacycline) for injection. For more information, please visit www.ljpc.com.
Company Details
- Employees
- 95
- Founded
- -
- Address
- 201 Jones Rd, Suite 400, Waltham,ma 02451,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- ljpc.com
- Keywords
- Pharmaceutical Manufacturing.
- HQ
- Waltham, MA
La Jolla Pharmaceutical Company Questions
La Jolla Pharmaceutical Company's website is ljpc.com
La Jolla Pharmaceutical Company's LinkedIn profile is https://www.linkedin.com/company/la-jolla-pharmaceutical-company
La Jolla Pharmaceutical Company has
95 employees.
View email and phone details for 95
employees at La Jolla Pharmaceutical Company.
La Jolla Pharmaceutical Company's industry is
Biotechnology Research
La Jolla Pharmaceutical Company's top competitors are
Biomarin Pharmaceutical Inc.,
Avara Pharmaceutical Services,
Innoviva Specialty Therapeutics, Inc.,
Pharmaceutical Company,
Novartis,
Sun Pharma,
Par Pharmaceutical,
Rovi Pharmaceutical Company,
Pfizer,
The Janssen Pharmaceutical Companies Of Johnson & Johnson.
La Jolla Pharmaceutical Company's categories are Biotechnology Research
La Jolla Pharmaceutical Company's founding year is 1989
